BPM31510 – A Unique Therapy Targeting Metabolism in GBM
Time: 4:45 pm
day: Conference Day 1
Details:
- Tumor metabolism is increasingly recognized as a key driver of glial tumors
- BPM31510 reverses Warburg Effect, and induces ROS in glioblastoma cells
- A frontline phase 2 clinical trial of BPM31510 is ongoing
